Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa — Stella

Home/Epidermolysis Bullosa Dystrophica/

View on ClinicalTrials.gov

Recruiting

Back to Epidermolysis Bullosa Dystrophica trials

Trial locations(1 site)

United States

Stanford University School of Medicine, Stanford, California

Key details

Sponsor

Stanford University

Enrollment target

~70 participants

Started

November 2009

Primary completion

December 2029

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.